Pace Logo

News Category: Pace Corporate

Pace® Analytical Services Adds Four Locations in Pennsylvania

Acquisition of Fairway Laboratories provides added local convenience to Pace® customers requiring environmental testing services Minneapolis, MN, November 8, 2022 – Pace® Analytical Services, the preferred provider of regulatory testing and analysis laboratory services and a division of Pace®, a science and technology company, today announced that it has acquired Fairway Laboratories, Inc., a full-service …

Pace® Analytical Services Adds Four Locations in Pennsylvania Read More »

Pace® Analytical Services Strengthens Presence in the Northeast Adding Anchor Location in New Jersey

Acquisition of 20,000 square foot laboratory adds capacity to support increasing demand for environmental testing and analysis services in New Jersey and New York City. Minneapolis, MN, October 25, 2022 – Pace® Analytical Services, the preferred provider of regulatory testing and analysis laboratory services and a division of Pace®, a science and technology company, today …

Pace® Analytical Services Strengthens Presence in the Northeast Adding Anchor Location in New Jersey Read More »

Hurricane Ian Update

On September 27th we let you know about the closing of the Pace® Oldsmar, Florida (Tampa Bay) laboratory. As of 12:00 PM EST today, September 28, we will be closing our Florida labs in Ormond Beach and Jacksonville until further notice. Pace® labs in Pompano Beach, Florida and Mobile, Alabama remain fully operational at this …

Hurricane Ian Update Read More »

Pace® Life Sciences Acquires Biopharma Global, Expanding FDA Regulatory Affairs Strategy and Consulting Capabilities to the Biotechnology and Pharmaceutical Markets

Acquisition allows Pace® to provide full-service regulatory strategy and consulting services to advance FDA submissions across a wide range of therapeutic classes. Minneapolis, MN, September 1, 2022 – Pace® Life Sciences, LLC, a full-service contract development and manufacturing organization (CDMO) and subsidiary of Pace®, ascience and technology company, announced today that it has acquired Biopharma …

Pace® Life Sciences Acquires Biopharma Global, Expanding FDA Regulatory Affairs Strategy and Consulting Capabilities to the Biotechnology and Pharmaceutical Markets Read More »

Pace® Obtains EPA Approval on Method for Detecting Dioxins and Dibenzofurans through GCMS/ MS technology

State-of-the-art technology allows labs to detect lower amounts of dioxins and dibenzofurans providing better test results, greater efficiency and selections. MINNEAPOLIS (July 28, 2022) — Pace® Analytical Services, a division of Pace® and the preferred provider of in-lab, mobile, and emergency onsite specialty-contaminant and regulatory testing and analysis services, and partner Shimadzu Scientific Instruments, Inc. …

Pace® Obtains EPA Approval on Method for Detecting Dioxins and Dibenzofurans through GCMS/ MS technology Read More »

Pace® Life Sciences Awarded Bronze Medal from EcoVadis for Sustainability Efforts

Company excels in Labor & Human Rights and Ethics performance for current Corporate Social Responsibility (CSR) Initiatives. Pace® Life Sciences, a division of Pace® Science and Technology Company, is pleased to announce that it has received a Bronze Award for its current state of sustainability. This award signifies that Pace® is in the top 50% …

Pace® Life Sciences Awarded Bronze Medal from EcoVadis for Sustainability Efforts Read More »

Pace® Receives DOD Accreditation for PFAS Testing Using EPA Draft Method 1633

PFAS testing by isotope dilution, a Pace® technique, is also cited in draft method. Minneapolis, MN, June 15, 2022 – Pace® Analytical Services, a division of Pace® Science and Technology Company and the preferred provider of in-lab, mobile, emergency onsite specialty contaminant, and regulatory testing and analysis services announced today they have received accreditation for …

Pace® Receives DOD Accreditation for PFAS Testing Using EPA Draft Method 1633 Read More »

Webinar: The Evolution of an NCE’s Suspension Formulation, from pre-GLP Studies to the Pharmacy Shelf

Pharmaceutical Technology hosts “The Evolution of an NCE’s Suspension Formulation, from pre-GLP Studies to the Pharmacy Shelf” – a webinar presented by Dave Barnes, Ph.D., Vice President of Scientific Affairs for Pace® Life Sciences. To watch it live, tune in on Thursday, April 14 at 11 AM EDT. REGISTER HERE REGISTER HERE This presentation focuses …

Webinar: The Evolution of an NCE’s Suspension Formulation, from pre-GLP Studies to the Pharmacy Shelf Read More »

Pace® Analytical Services Strengthens Presence in the Northeast Adding Five Laboratories

Added lab capacity supports increasing demand for environmental testing and analysis services in Connecticut, New Jersey, and the Hudson Valley region of New York. Minneapolis, MN, March 15, 2022 – Pace® Analytical Services, a division of Pace® and the preferred provider of in-lab, mobile, emergency onsite specialty-contaminant, and regulatory testing and analysis services, today announced …

Pace® Analytical Services Strengthens Presence in the Northeast Adding Five Laboratories Read More »

Pace® Analytical Services Adds Four Midwest Laboratory Locations through Acquisition of PDC Laboratories, Inc.

Added lab capacity supports increasing demand for environmental testing and analysis services Minneapolis, MN, December 20, 2021 – Pace® Analytical Services, a division of Pace® and the preferred provider of in-lab, mobile, emergency onsite specialty-contaminant, and regulatory testing and analysis services, today announced that it has acquired PDC Laboratories, Inc. PDC Laboratories specializes in water …

Pace® Analytical Services Adds Four Midwest Laboratory Locations through Acquisition of PDC Laboratories, Inc. Read More »